Identification of a NCR+/NKG2D+/LFA-1 low/CD94- immature human NK cell subset

Cytometry Part A

Volumn 75, Issue 11, 2009, Pages 893-901

  Zamai, Loris ^a,b   Galeotti, Laura ^a   Del Zotto, Genny ^a   Canonico, Barbara ^a   Mirandola, Prisco ^c   Papa, Stefano ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b LABORATORI NAZIONALI DEL GRAN SASSO   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Adhesion molecules; Cell differentiation; Human natural killer cells

Indexed keywords

CD161 ANTIGEN; CD18 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; FLT3 LIGAND; INTEGRIN; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELL MATURATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11A; ANTIGENS, CD11B; ANTIGENS, CD18; CELL ADHESION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, IMMUNOLOGIC; TIME FACTORS;

EID: 71049167297     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20789     Document Type: Article

References (31)

1. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002;3:6-8.
2. Braud VM, Allan DS, O'Callaghan CA,. Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:740-743.
3. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med 1996;184:1845-1856.
4. Sivori S, Falco M, Marcenaro E, Parolini S, Biassoni R, Bottino C, Moretta L, Moretta A. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc Natl Acad Sci USA 2002;99:4526-4531. (Pubitemid 34286018)
5. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-640.
6. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, Münz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004;172:1455-1462. (Pubitemid 38116788)
7. Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996;87:2632-2640. (Pubitemid 26102211)
8. Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998;92:3647-3657. (Pubitemid 28525190)
9. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev 2006;20:123-137. (Pubitemid 43786166)
10. Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005;22:295-304. (Pubitemid 40387472)
11. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;188:2375-2380. (Pubitemid 29028510)
12. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 2002;99:1273-1281. (Pubitemid 34547081)
13. Freud AG, Yokohama A, Becknell B, Lee MT, Mao HC, Ferketich AK, Caligiuri MA. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006;203:1033-1043.
14. Grzywacz B, Kataria N, Sikora M, Oostendorp RA, Dzierzak EA, Blazar BR, Miller JS, Verneris MR. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 2006;108:3824-3833. (Pubitemid 44864565)
15. Medvedev AE, Johnsen AC, Haux J, Steinkjer B, Egeberg K, Lynch DH, Sundan A, Espevik T. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997;9:394-404. (Pubitemid 27249972)
16. Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine 1999;11:664-672. (Pubitemid 29427999)
17. Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity. Blood 2004;104:2418-2424. (Pubitemid 39331842)
18. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol 1990;145:3194-3201.
19. Zamai L, Ponti C, Mirandola P, Gobbi G, Papa S, Galeotti L, Cocco L, Vitale M. Natural killer cells and cancer. J Immunol 2007;178:4011-4016.
20. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001;19:291-330. (Pubitemid 32368038)
21. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006;6:520-531.
22. Frey M, Packianathan NB, Fehniger TA, Ross ME, Wang WC, Stewar CC, Caligiuri MA, Evans SS. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998;161:400-408. (Pubitemid 28285548)
23. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006;214:56-72. (Pubitemid 44707902)
24. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003;101:3730-3740. (Pubitemid 36857966)
25. - bone marrow cells. J Immunol 2003;171:683-690.
26. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002;3:523-528.
27. Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Scand J Immunol 2007;65:126-138.
28. Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2001;2:917-924.
29. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001;97:3146-3151.
30. Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 2001;98:705-713.
31. Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur J Immunol 1998; 28:1991-2002. (Pubitemid 28271716)